X
Adcetris cleared by NICE in aggressive blood cancer
https://pharmaphorum.com/news/takedas-adcetris-cleared-nhs-funding-aggressive-blood-cancer/
NICE
Show ambition with UK life sciences plan, Novartis tells government
August 25, 2017Drugmaker concerned over access to new drugs
NICE wants to axe funding for two thyroid cancer drugs
August 23, 2017NICE unconvinced by survival data from Ipsen and Sanofi drugs
Pfizer objects to NICE methods in leukaemia drug rejection
August 21, 2017NICE close to clearing Cancer Drugs Fund backlog
August 10, 2017Only five drugs left to assess from old scheme.
NICE recommends Celgene pancreatic cancer drug
August 4, 2017Abraxane finally gets NHS funding following price cut.
Roche’s Tecentriq hits trouble with NICE in bladder cancer
August 3, 2017Cancer Drugs Fund could cover costs in first line use.
Teva’s Cinqaero to challenge Nucala after clearing NICE
July 20, 2017Discount swings NICE decision, drug will compete with GSK rival
